Canada: Registrar's Decision Denying Third Request For Extension Of Time To File Evidence Upheld (Intellectual Property Weekly Abstracts Bulletin — Week of August 29 )

Trademark Decisions

Registrar's decision denying third request for extension of time to file evidence upheld
Trademark Tools Inc. v. Miller Thomson LLP
, 2016 FC 971

The Court dismissed Trademark Tools' appeal of the Registrar's decision denying its third request for an extension of time to file evidence. Pursuant to subsection 45(1) of the Trade-Marks Act, Trademark Tools was called upon by the Registrar of Trademarks to provide evidence of the use of its trademark within a specified time frame. Following two requests for extensions of time to file this evidence, the Registrar denied Trademark Tools' third request and expunged Trademark Tools' trademark for failure to show use.

While Trademark Tools' new affidavit was admissible at the Hearing, the Court found that it did not provide evidence of use. The Court also noted that the use of a variant of the trademark did not qualify as use. Apart from the use of the word and spelling of "logix", the updated mark did not maintain the dominate features of the registered trademark. Finally, the Court found that there were no special circumstances that would excuse non-use of the mark at issue. The appeal was dismissed.

Copyright Decisions

Repeat offender ordered to pay $100,000 in damages for selling five infringing copies of Microsoft software
Microsoft Corporation v. Liu, 2016 FC 950

Microsoft has been awarded damages and an injunction against the unauthorized copying of several of its programs by the individual defendant. The Court awarded $50,000 in statutory damages, $50,000 as exemplary and punitive damages, $40,000 in costs, plus interest.

Prior to this application Microsoft and Mr. Liu had settled two separate instances of copyright infringement, one in 2010 and the other in 2012. The 2012 settlement included a court ordered injunction on consent. A third alleged instance occurred a month after the Federal Court had issued the injunction, but this does not appear to form part of this application.

The within proceeding related to further alleged infringements occurring in October 2013 and February 2015.  In 2013 a private investigator visited a retail store where he was offered a computer containing Microsoft software that would not come with a DVD or a licence. The private investigator paid cash for the computer and obtained a business card from the proprietor, Mr. Liu.

In February 2015 the private investigator returned to the store and bought a refurbished computer with Microsoft software on the computer without a certificate of authenticity, DVD or licence. This computer was sold by a different employee, who had installed the Microsoft software using a hard drive handed to him by Mr. Liu.

The Court found Microsoft owns the copyright in the Microsoft programs and that Mr. Liu reproduced and copied Microsoft's computer programs and sold unlicensed copies of them to the private investigator in October 2013. This was found to constitute copyright infringement.

However the Court did not find that Mr. Liu was responsible for the February 2015 infringement. It was Mr. Liu's co-worker who made the sale and installed the software. While Microsoft asserted Mr. Liu was liable for authorizing the infringement, the nature of the relationship between Mr. Liu and the co-worker was not clear. It was not established that Mr. Liu had sufficient control or direction over Henry's actions to establish vicarious or joint liability for the infringement on February 3, 2015.

In the Court's view, someone who merely provides the equipment that could be used to infringe copyright is not liable or responsible for any subsequent violation of copyright that might occur when that equipment is used by someone else to infringe a copyrighted work. This was held to be akin to the self-service photocopiers made available to patrons of the library in CCH Canadian Ltd. v. Law Society of Upper Canada, 2004 SCC 13, [2004] 1 SCR 339 at paras 42 to 46.

After finding at least one instance of copyright infringement, the Court declined to award the maximum statutory damages. The Court noted there was no evidence as to Mr. Liu's sales of unlicensed software, or the profit generated by the infringing activity, on any date. Mr. Liu's conduct was not found to be as egregious as the defendant in some other cases and there was only a single instance of copyright infringement found, albeit for five computer programs. An award of full statutory damages, or $100,000 for the five works, was held to be out of proportion of any profit he may have made. However, the Court noted the failure to abide by the previous settlement agreements and thus the Court provided an award to deter future infringement. Thus, $10,000 was awarded for each infringement, totalling $50,000.

Punitive damages totalling $50,000 were awarded in light of the general disregard for the Court's prior injunction, the need for denunciation and the ongoing nature of the infringements. A $40,000 costs award was also provided based on a draft bill of costs of $71,686.

Supreme Court Leaves to Intervene Granted

AstraZeneca Canada Inc., v. Apotex Inc., (SCC #36654) — leave to intervene granted

The Supreme Court has granted leave to intervene to the following: Innovative Medicines Canada and BIOTECanada (jointly); the Centre for Intellectual Property Policy; the Canadian Generic Pharmaceutical Association; the Fédération internationale des conseils en propriété intellectuelle; the Intellectual Property Owners Association and the Intellectual Property Institute of Canada.

The Supreme Court had previously granted AstraZeneca leave to appeal in its application, which asks the correct applicable standard for patent utility in Canada and whether a promised utility doctrine properly exists, see our summary here.

Industry News

Health Canada published a Notice – Health Canada and United States Food and Drug Administration (US FDA) Joint Public Consultation on International Council on Harmonisation (ICH) Guidelines for Registration of Pharmaceuticals for Human Use

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions